Medical expert of the article
New publications
Preparations
Pairemol
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Pyremol (synonyms - Paracetamol, Panadol, Paramol, Tylenol, Aminodol, Dimindol, Dolanax, Mialgin, Cetadol, etc.) refers to analgesics-antipyretics, close to non-steroidal anti-inflammatory drugs.
Indications Pairemol
Anesthetic, antipyretic, and also minor anti-inflammatory properties of Pyremol cause the expediency of its use for the removal of mild and moderate pain of various etiologies, including:
Indications for the use of this drug as an antipyretic are diseases accompanied by febrile conditions.
Release form
Form release: coated tablets of 500 mg of active ingredient (paracetamol).
Pharmacodynamics
Pharmacodynamics Pyremol is based on the action of paracetamol (N-4-hydroxyphenylacetamide), which by blocking the CNS-synthesized isoform of cyclooxygenase COX-3 inhibits the production of the prostaglandin mediator in the brain. As a result, the pain is relieved. Antipyretic effect is achieved as a result of the fact that paracetamol reduces the degree of excitability of thermoreceptors that transmit the signal to the center of heat production of the hypothalamus. However, the process of synthesis of inflammation conductors does not affect paracetamol, since its effect on cytokines, endothelial cells and platelet aggregation is neutralized by cellular enzymes that accelerate oxidative reactions in cells.
Pharmacokinetics
The active substance Pyremola has a high absorption rate and is adsorbed in the small intestine, getting into tissues with blood flow. About 20% of paracetamol binds to blood plasma proteins. The drug penetrates through the BBB (and enters the breast milk). Approximately 25 minutes after taking the therapeutic dose of Peyrenol, its maximum concentration is achieved.
Transformation of the drug occurs in the liver, and inactive metabolites are excreted from the body by the kidneys. Half-life is an average of three hours. Some of the active substance Pairolone is metabolized by removing from the molecule an acetyl group, resulting in the formation of an easily oxidizable isomer of aminophenol (paraaminophenol), which, with significant doses of the drug, has a toxic effect on the liver.
Dosing and administration
Pylemol tablets are taken orally - after eating, with plenty of fluids. A single therapeutic dose for adults is 1 tablet (0.5 g), the maximum single dose is 1.5 g, the maximum daily dose is 3 g.
The maximum allowable daily intake for children is: 3-6 years - 1-2 g (based on 60 mg per 1 kg of body weight of the child), three times a day; 9-12 years - 2 grams (in 3-4 sessions).
Use Pairemol during pregnancy
The appointment and use of Pyrehemol during pregnancy and during breastfeeding requires caution.
Contraindications
Contraindications to the use of Pyremol are: hypersensitivity to paracetamol, hepatic and renal failure, children under three years of age.
Side effects Pairemol
Among the possible side effects of the drug are: allergic reactions (skin rashes, itching, angioedema); nausea; pain in the stomach; decreased heart rate; renal colic; increased blood pressure associated with damage to the glomeruli of the kidneys (glomerulonephritis); presence of pus in the urine in the absence of pathogenic microflora.
Negative effects on hematopoiesis can be expressed in anemia, a decrease in the number of platelets in the blood (thrombocytopenia), a decrease in the granulocyte count in the blood (agranulocytosis), a decrease in the number of leukocytes (leukopenia), and a rise in the blood of methemoglobin (methemoglobinemia). A significant amount of methemoglobin (which can not transfer oxygen from the lungs to the tissues) leads to cyanosis and oxygen starvation.
[1]
Overdose
Overdose of Pyreemol (paracetamol) leads to toxic effects on the liver and is manifested by symptoms such as dizziness, nausea, vomiting, pale skin and mucous membranes. With these signs, urgent hospitalization is required. As an antidote in the overdose of paracetamol antitoxic agent acetylcysteine (intravenous injection or ingestion) is used.
Interactions with other drugs
The interactions of this drug with other pharmacological preparations are as follows:
- paracetamol enhances the action of antagonists of vitamin K, which increase blood coagulability (coagulants of indirect action),
- paracetamol increases the effect of salicylic acid, caffeine, codeine and antispasmodic drugs;
- hypnotics (barbiturates) and antiepileptic drugs reduce the antipyretic effect of paracetamol and increase its toxic effect on the liver.
Storage conditions
Store Peyrenol at a temperature not higher than + 25 ° C, out of the reach of children.
Shelf life
Shelf life is 2 years from the date of issue.
Attention!
To simplify the perception of information, this instruction for use of the drug "Pairemol" translated and presented in a special form on the basis of the official instructions for medical use of the drug. Before use read the annotation that came directly to medicines.
Description provided for informational purposes and is not a guide to self-healing. The need for this drug, the purpose of the treatment regimen, methods and dose of the drug is determined solely by the attending physician. Self-medication is dangerous for your health.